Wird geladen...
Anti-Diabetic Agents and Heart Failure ― Response to the CARMELINA Study ―
According to cardiovascular outcome trials, some anti-diabetic drugs can improve cardiovascular outcomes in patients with type 2 diabetes. Sodium glucose cotransporter 2 inhibitors (empagliflozin, canagliflozin, and dapagliflozin) have a strong preventive effect on both hospitalization for heart fai...
Gespeichert in:
| Veröffentlicht in: | Circ Rep |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The Japanese Circulation Society
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7925121/ https://ncbi.nlm.nih.gov/pubmed/33693068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-18-0011 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|